… CNS after residing transiently within the lung tissues. Inside the lung tissues, they move along
and … We detected that the lung constitutes a niche not only for activated T cells but also for …

… The cells were initially located in the lung bronchi (air passages) and alveoli (terminal air
sacs), before accumulating in dense immune-cell clusters known as bronchus-associated …

… This systematic review with network meta-analysis compared the efficacy and safety of
currently licensed second-line treatments in patients with late stage non-small cell lung cancer (…

… the lung? The 3 themes of the workshop were: (1) techniques to study drug transporter
expression and actions in the lungs; … licensed inhaled molecules are substrates are present in the …

… article’s Creative Commons license, unless indicated otherwise in a credit line to the material.
If material is not included in the article’s Creative Commons license and your intended use …

… Lung cancer is one of the most commonly diagnosed cancers and the leading cause of … [1],
with non-small lung cancer (NSCLC) accounting for 85%–90% of all forms of lung cancer [2]. …

… lacks lung-resident CD11b + DCs (34), we show that only lung CD11b + DCs are critically
required for Th2 priming and development of allergy. In contrast, lung … that lung epithelial cell-…

… We included Maastricht category III DCD lung transplants and all DBD lung transplants
performed between January 2012 and February 2017 at our center. There were 21 transplants …

… issued, a patent to CA2944922A1 pending and licensed, a patent to CA2966282A1 issued,
a patent to US10091986B2 issued and licensed, and a patent to WO201818100A1 issued. …

… the care of patients with lung adenocarcinomas. The Lung Cancer Mutation Consortium was
formed to perform multiplexed assays testing adenocarcinomas of the lung for drivers in 10 …